These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 9469643
1. The effects of a newly developed nonsteroidal anti-inflammatory drug (M-5011) on arachidonic acid metabolism in rheumatoid synovial fibroblasts. Tobetto K, Yamamoto Y, Kataoka M, Ando T, Sugimoto K, Himeno M. Jpn J Pharmacol; 1997 Dec; 75(4):371-9. PubMed ID: 9469643 [Abstract] [Full Text] [Related]
7. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid. Chulada PC, Langenbach R. J Pharmacol Exp Ther; 1997 Feb 25; 280(2):606-13. PubMed ID: 9023270 [Abstract] [Full Text] [Related]
8. Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells. Kawai S, Nishida S, Kato M, Furumaya Y, Okamoto R, Koshino T, Mizushima Y. Eur J Pharmacol; 1998 Apr 17; 347(1):87-94. PubMed ID: 9650852 [Abstract] [Full Text] [Related]
11. In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs. Cordero JA, Camacho M, Obach R, Domenech J, Vila L. Eur J Pharm Biopharm; 2001 Mar 17; 51(2):135-42. PubMed ID: 11226820 [Abstract] [Full Text] [Related]
12. Cyclooxygenase-2 inhibitors decrease interleukin-1beta-stimulated prostaglandin E2 and IL-6 production by human gingival fibroblasts. Tipton DA, Flynn JC, Stein SH, Dabbous MKh. J Periodontol; 2003 Dec 17; 74(12):1754-63. PubMed ID: 14974816 [Abstract] [Full Text] [Related]
15. In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators. Henrotin Y, de Leval X, Mathy-Hartet M, Mouithys-Mickalad A, Deby-Dupont G, Dogné JM, Delarge J, Reginster JY. Inflamm Res; 2001 Aug 17; 50(8):391-9. PubMed ID: 11556519 [Abstract] [Full Text] [Related]
16. Participation of cyclooxygenase-1 in prostaglandin E2 release from synovitis tissue in primary osteoarthritis in vitro. Knorth H, Dorfmüller P, Lebert R, Schmidt WE, Wittenberg RH, Heukamp M, Wiese M, Willburger RE. Osteoarthritis Cartilage; 2004 Aug 17; 12(8):658-66. PubMed ID: 15262246 [Abstract] [Full Text] [Related]
17. The molecular mechanism of inhibition of interleukin-1beta-induced cyclooxygenase-2 expression in human synovial cells by Tripterygium wilfordii Hook F extract. Maekawa K, Yoshikawa N, Du J, Nishida S, Kitasato H, Okamoto K, Tanaka H, Mizushima Y, Kawai S. Inflamm Res; 1999 Nov 17; 48(11):575-81. PubMed ID: 10598013 [Abstract] [Full Text] [Related]
18. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Riendeau D, Charleson S, Cromlish W, Mancini JA, Wong E, Guay J. Can J Physiol Pharmacol; 1997 Sep 17; 75(9):1088-95. PubMed ID: 9365818 [Abstract] [Full Text] [Related]
19. Interleukin-4 inhibits prostaglandin E2 production by freshly prepared adherent rheumatoid synovial cells via inhibition of biosynthesis and gene expression of cyclo-oxygenase II but not of cyclo-oxygenase I. Sugiyama E, Taki H, Kuroda A, Mino T, Yamashita N, Kobayashi M. Ann Rheum Dis; 1996 Jun 17; 55(6):375-82. PubMed ID: 8694577 [Abstract] [Full Text] [Related]